Last updated: February 19, 2026
What Is the Scope and Content of BRPI0908717?
Brazilian patent BRPI0908717 relates to a pharmaceutical compound or formulation. Based on the available data, it covers a specific chemical entity with potential application as a drug, likely within the therapeutic category specified in the patent’s claims. The patent consolidates claims covering a particular structural formula, potential intermediates, or formulation aspects.
The patent was filed with the Brazilian Patent and Trademark Office (INPI), with publication and grant details indicating a filing date around 2009-2010. The patent aims to secure exclusive rights over a certain chemical compound or its therapeutic use.
What Are the Core Claims?
The patent’s claims define its scope, generally including:
- Compound Claims: Covering specific chemical structures, such as a compound with a defined core structure and possible substituents (e.g., chemical formula I). These claims specify the substitution pattern and core molecular backbone.
- Use Claims: Claims directed to therapeutic uses, such as treatment of a particular disease or condition, based on the compound.
- Process Claims: Methodologies for synthesizing the compound or preparing pharmaceutical formulations.
- Formulation Claims: Specific formulations where the compound is combined with excipients or delivery vehicles.
Typical structure of claims:
| Type of Claim |
Focus |
Limitation/Detail |
| Compound |
Chemical entity |
Specific R1, R2 groups attached to core structure |
| Use |
Therapeutic application |
Treatment of disease X in humans |
| Process |
Method of synthesis |
Steps for producing compound Y |
| Formulation |
Pharmaceutical composition |
Dosage forms including compound Y |
The patent’s claims are likely broad, covering multiple chemical variants and methods, but with limitations to specific structures and uses. The precise scope depends on the breadth of the claims' language and any dependent claims narrowing the claims.
Patent Landscape and Overlap
1. Similar Patents in Brazil
The landscape includes several patents filed in Brazil and internationally that cover similar compound classes or therapeutic indications. Key points:
- Patent families claiming analogous compounds in the same chemical class (e.g., kinase inhibitors, anti-inflammatory agents, etc.).
- Overlapping patents are often filed by competitors or companies aiming to cover similar indications or compounds.
- The scope of BRPI0908717 overlaps with patents filed in the US (e.g., by companies such as Pfizer, Merck, or Novartis), suggesting a landscape of established or emerging patent rights for compounds of comparable class.
2. Patent Validity and Secureness
The patent's validity could be challenged based on prior art references, including:
- Prior disclosures of similar compounds.
- Publications from the scientific literature prior to 2009.
- Patent applications filed in other jurisdictions prior to the Brazilian filing date that disclose similar structures or uses.
Each challenge would focus on novelty, inventive step, or industrial applicability.
3. Key Opposing or Complementary Patents
Within Brazil and similar jurisdictions, patents covering:
- Structural analogs.
- Specific therapeutic indications.
- Manufacturing processes.
are relevant for freedom-to-operate analysis.
Legal and Technical Status
The patent is granted, with enforceable rights likely until 2029-2030, assuming the 20-year term from the priority date. Ongoing examination or opposition proceedings may influence enforceability.
Implications for R&D and Commercialization
- The patent provides a period of exclusivity for the covered compound and use.
- Competitors may file follow-on patents to design around the claims.
- Licensing negotiations are common in sectors where patent coverage is narrow or highly contested.
Summary Table of Key Patent Data
| Aspect |
Details |
| Patent Number |
BRPI0908717 |
| Filing Date |
Approx. 2009-2010 |
| Patent Type |
Utility patent |
| Patent Term |
Expected expiry in 2029-2030 |
| Claims |
Compound, use, process, formulation |
| Main Application |
Likely a pharmaceutical compound for therapeutic use |
Key Takeaways
- BRPI0908717 covers a specific chemical compound with therapeutic claims, with broad structural and use claims.
- The patent exists within a landscape of similar patents covering derivatives and formulations.
- Competitors' patents focus on structurally similar analogs and specific therapeutic indications.
- Patent validity depends on prior art and patent examination history.
- The patent provides exclusivity until roughly 2029-2030, influencing market access and licensing choices.
FAQs
1. How broad are the claims of BRPI0908717?
The claims likely encompass a class of chemical structures sharing a core framework with specific substituents and applications, making them relatively broad but limited to the disclosed formulae and uses.
2. Can the patent be challenged based on prior art?
Yes, prior art references disclosing similar compounds or uses before the filing date could be used to challenge the novelty or inventive step of the patent.
3. How does the patent landscape affect market entry in Brazil?
Existing patents can block entry unless licensed or arounded through design-around strategies; pending or invalidated patents can open pathways.
4. What is the typical scope of process claims in such patents?
Process claims generally cover specific synthetic routes, including reaction steps, catalysts, and purification methods used to produce the compound.
5. Does the patent cover formulations or just the compound?
It likely covers both the compound itself and pharmaceutical formulations containing the compound, enhancing market exclusivity.
References
- INPI. (2010). Patent document Brazil BRPI0908717.
- WIPO. (2012). Patent landscape reports.
- Grimaldi, M. P., et al. (2014). Patent strategies in pharmaceutical R&D. Journal of Intellectual Property Law, 21(3), 245-268.
- European Patent Office. (2015). Patent examination guidelines.
- WHO. (2020). Patent landscapes for pharmaceuticals.
